TuHURA Biosciences Draws $1.5M on $50M Revolving Credit Facility

What Happened

• TuHURA Biosciences, Inc. filed a Form 8‑K on July 29, 2026 reporting that it borrowed $1,500,000 on July 28, 2026 under a previously disclosed revolving Loan Agreement with Parkview Holdings One LLC.
• The Loan Agreement, dated April 21, 2026, provides a revolving credit facility with up to $50 million in availability and a maturity date of April 21, 2031. The company expects to use the $1.5M draw for general corporate purposes.

Key Details

• Lender: Parkview Holdings One LLC.
• Facility: Revolving credit facility with maximum availability of $50,000,000.
• Recent draw: $1,500,000 received and borrowed on July 28, 2026.
• Maturity: April 21, 2031. The full Loan Agreement was previously filed as Exhibit 4.1 to the company’s Form 8‑K on April 22, 2026.

Why It Matters

• The draw increases TuHURA’s near‑term liquidity by $1.5M, which may help fund operations and development in the short term.
• The filing cautions that availability under the facility is subject to conditions and that the company may still need additional capital; it also notes a potential conflict of interest because the lender is affiliated with the company’s largest stockholder.
• Investors should monitor future filings for updates on cash runway, additional draws or repayments, and any material terms or covenants in the loan that could affect financial flexibility.